Bellevue Group Ag Beam Therapeutics Inc. Transaction History

Bellevue Group Ag

  • $5.93 Billion
  • Q3 2024

A detailed history of Bellevue Group Ag transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 1,518,121 shares of BEAM stock, worth $40.1 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
1,518,121
Previous 1,418,121 7.05%
Holding current value
$40.1 Million
Previous $33.2 Million 11.94%
% of portfolio
0.63%
Previous 0.56%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$22.57 - $33.14 $2.26 Million - $3.31 Million
100,000 Added 7.05%
1,518,121 $37.2 Million
Q2 2024

Aug 14, 2024
BUY
$21.22 - $32.66 $4.77 Million - $7.35 Million
225,000 Added 18.86%
1,418,121 $33.2 Million
Q1 2024

May 15, 2024
BUY
$23.46 - $45.07 $11.7 Million - $22.5 Million
498,300 Added 71.72%
1,193,121 $39.4 Million
Q3 2023

Nov 14, 2023
SELL
$23.01 - $32.46 $13,806 - $19,476
-600 Reduced 0.09%
694,821 $16.7 Million
Q1 2023

May 15, 2023
SELL
$30.15 - $48.79 $39,195 - $63,427
-1,300 Reduced 0.19%
695,421 $21.3 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $4.59 Million - $6.45 Million
125,000 Added 21.86%
696,721 $27.2 Million
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $35,811 - $63,279
-900 Reduced 0.16%
571,721 $27.2 Million
Q2 2022

Aug 11, 2022
SELL
$29.86 - $62.36 $304,572 - $636,072
-10,200 Reduced 1.75%
572,621 $22.2 Million
Q1 2022

May 13, 2022
SELL
$53.73 - $82.16 $1.61 Million - $2.46 Million
-30,000 Reduced 4.9%
582,821 $33.4 Million
Q2 2021

Aug 12, 2021
BUY
$64.12 - $128.71 $2.95 Million - $5.92 Million
46,000 Added 8.12%
612,821 $78.9 Million
Q1 2021

May 12, 2021
BUY
$71.28 - $120.75 $12.1 Million - $20.5 Million
170,000 Added 42.84%
566,821 $45.4 Million
Q4 2020

Feb 16, 2021
BUY
$22.24 - $95.63 $8.83 Million - $37.9 Million
396,821 New
396,821 $32.4 Million

Others Institutions Holding BEAM

# of Institutions
235
Shares Held
75.1M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.86B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email